133 related articles for article (PubMed ID: 37937786)
21. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
22. Circulating EBV DNA and ¹⁸F-FDG PET scan in the diagnosis and monitoring of nasopharyngeal carcinoma.
Wang WY; Lin PJ; Lin JC
J Formos Med Assoc; 2012 Feb; 111(2):118-9. PubMed ID: 22370292
[No Abstract] [Full Text] [Related]
23. A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
Tan GW; Sivanesan VM; Abdul Rahman FI; Hassan F; Hasbullah HH; Ng CC; Khoo AS; Tan LP
Int J Cancer; 2019 Oct; 145(8):2260-2266. PubMed ID: 30698824
[TBL] [Abstract][Full Text] [Related]
24. Early screening of nasopharyngeal carcinoma.
Yuan Y; Ye F; Wu JH; Fu XY; Huang ZX; Zhang T
Head Neck; 2023 Oct; 45(10):2700-2709. PubMed ID: 37552128
[TBL] [Abstract][Full Text] [Related]
25. The human oral - nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma.
Hao Y; Zeng Z; Peng X; Ai P; Han Q; Ren B; Li M; Wang H; Zhou X; Zhou X; Ma Y; Cheng L
Front Cell Infect Microbiol; 2022; 12():1013920. PubMed ID: 36530430
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
27. [Application of immunoenzymic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma (author's transl)].
Zeng Y; Liu Y; Liu CR; Chen SW; Wei JE; Zhu JS; Zai HJ
Zhonghua Zhong Liu Za Zhi; 1979; 1(1):2-7. PubMed ID: 233230
[No Abstract] [Full Text] [Related]
28. Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma.
Chang C; Middeldorp J; Yu KJ; Juwana H; Hsu WL; Lou PJ; Wang CP; Chen JY; Liu MY; Pfeiffer RM; Chen CJ; Hildesheim A
J Med Virol; 2013 Mar; 85(3):524-9. PubMed ID: 23280934
[TBL] [Abstract][Full Text] [Related]
29. An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals.
Rao DP; Gu J; Meng XH; Zhang Q; Fu MQ; Liu Y; Chen F; Cao SM; Hong MH; Liu Q
J Int Med Res; 2012; 40(2):525-36. PubMed ID: 22613413
[TBL] [Abstract][Full Text] [Related]
30. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
[TBL] [Abstract][Full Text] [Related]
31. [The following-up study of high-risk and moderate-risk groups defined by EB virus serology test at the nasopharyngeal carcinoma screening programme].
Lian S; Ji M; Wu B; Yu X
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jan; 49(1):26-30. PubMed ID: 25876491
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma.
Zhou X; Cao SM; Cai YL; Zhang X; Zhang S; Feng GF; Chen Y; Feng QS; Chen Y; Chang ET; Liu Z; Adami HO; Liu J; Ye W; Zhang Z; Zeng YX; Xu M
Nat Commun; 2021 Aug; 12(1):5189. PubMed ID: 34465768
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with early diagnosis in pediatric vs adult nasopharyngeal carcinoma.
Li C; Wang Y
Acta Otolaryngol; 2018 Jan; 138(1):56-59. PubMed ID: 28875765
[TBL] [Abstract][Full Text] [Related]
34. [The clinical significance of EBV DNA analysis in nasopharyngeal carcinoma screening].
Wang L; Song YL; Huang SM; Tao HX; Zhao YQ; Yan N; Xu DY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 32(4):298-301. PubMed ID: 29798510
[No Abstract] [Full Text] [Related]
35. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
36. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations.
Han BL; Xu XY; Zhang CZ; Wu JJ; Han CF; Wang H; Wang X; Wang GS; Yang SJ; Xie Y
Asian Pac J Cancer Prev; 2012; 13(6):2577-81. PubMed ID: 22938423
[TBL] [Abstract][Full Text] [Related]
37. Strategies to enhance nasopharyngeal carcinoma screening in patients with adult-onset idiopathic inflammatory myopathies.
Tang IYK; Li TWL; Luk LTH; Ho B; Ho R; Lai BTL; Lee PML; So H
Int J Rheum Dis; 2024 Jun; 27(6):e15215. PubMed ID: 38873854
[No Abstract] [Full Text] [Related]
38. The prevalence and prevention of nasopharyngeal carcinoma in China.
Cao SM; Simons MJ; Qian CN
Chin J Cancer; 2011 Feb; 30(2):114-9. PubMed ID: 21272443
[TBL] [Abstract][Full Text] [Related]
39. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
40. Invited commentary: Epstein-Barr virus-based screening for the early detection of nasopharyngeal carcinoma: a new frontier.
Hildesheim A
Am J Epidemiol; 2013 Feb; 177(3):251-3. PubMed ID: 23255781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
